A multi-platform metabolomics approach identifies highly specific biomarkers of bacterial diversity in the vagina of pregnant and non-pregnant women

Scientific Reports

Volumn 5, Issue , 2015, Pages

  McMillan, Amy ^a   Rulisa, Stephen ^b   Sumarah, Mark ^c   Macklaim, Jean M ^a   Renaud, Justin ^c   Bisanz, Jordan E ^a   Gloor, Gregory B ^a   Reid, Gregor ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF RWANDA   (Rwanda)

^c AGRICULTURE AND AGRI FOOD CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2-HYDROXYISOVALERIC ACID; BIOLOGICAL MARKER; OXYBATE SODIUM; VALERIC ACID DERIVATIVE;

ADULT; BIODIVERSITY; FEMALE; GARDNERELLA VAGINALIS; HUMAN; ISOLATION AND PURIFICATION; LACTOBACILLUS; METABOLISM; METABOLOMICS; MICROBIOLOGY; MICROFLORA; MIDDLE AGED; PREGNANCY; RWANDA; VAGINA; VAGINITIS; YOUNG ADULT;

ADULT; BIODIVERSITY; BIOMARKERS; FEMALE; GARDNERELLA VAGINALIS; HUMANS; LACTOBACILLUS; METABOLOMICS; MICROBIOTA; MIDDLE AGED; PREGNANCY; RWANDA; SODIUM OXYBATE; VAGINA; VAGINOSIS, BACTERIAL; VALERATES; YOUNG ADULT;

EID: 84942134765     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep14174     Document Type: Article

References (58)

1. Ravel, J. et al. Vaginal microbiome of reproductive-age women. Proc. Natl. Acad. Sci. USA 108, Suppl 1, 4680-4687 (2011).
2. Hummelen, R. et al. Deep sequencing of the vaginal microbiota of women with HIV. PLoS One 5, e12078 (2010).
3. Fredricks, D. N. , Fiedler, T. L. Marrazzo, J. M. Molecular identification of bacteria associated with bacterial vaginosis. N. Engl. J. Med. 353, 1899-1911 (2005).
4. Koumans, E. H. et al. The prevalence of bacterial vaginosis in the United States, 2001-2004; associations with symptoms, sexual behaviors, and reproductive health. Sex. Transm. Dis. 34, 864-869 (2007).
5. Klebanoff, M. A. et al. Vulvovaginal symptoms in women with bacterial vaginosis. Obstet. Gynecol. 104, 267-272 (2004).
6. Sobel, J. D. , Karpas, Z. Lorber, A. Diagnosing vaginal infections through measurement of biogenic amines by ion mobility spectrometry. Eur. J. Obstet. Gynecol. Reprod. Biol. 163, 81-84 (2012).
7. Wolrath, H. , Forsum, U. , Larsson, P. G. Boren, H. Analysis of bacterial vaginosis-related amines in vaginal fluid by gas chromatography and mass spectrometry. J. Clin. Microbiol. 39, 4026-4031 (2001).
8. Wolrath, H. , Stahlbom, B. , Hallen, A. Forsum, U. Trimethylamine and trimethylamine oxide levels in normal women and women with bacterial vaginosis reflect a local metabolism in vaginal secretion as compared to urine. APMIS 113, 513-516 (2005).
9. Sha, B. E. et al. Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis. J. Infect. Dis. 191, 25-32 (2005).
10. Das, T. R. , Jahan, S. , Begum, S. R. Akhtar, M. F. Association between bacterial vaginosis and preterm delivery. Mymensingh Med. J. 20, 115-120 (2011).
11. Nugent, R. P. , Krohn, M. A. Hillier, S. L. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J. Clin. Microbiol. 29, 297-301 (1991).
12. Amsel, R. et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am. J. Med. 74, 14-22 (1983).
13. Chaijareenont, K. , Sirimai, K. , Boriboonhirunsarn, D. Kiriwat, O. Accuracy of Nugents score and each Amsels criteria in the diagnosis of bacterial vaginosis. J. Med. Assoc. Thai. 87, 1270-1274 (2004).
14. Sha, B. E. et al. Utility of Amsel criteria, Nugent score, and quantitative PCR for Gardnerella vaginalis, Mycoplasma hominis, and Lactobacillus spp. for diagnosis of bacterial vaginosis in human immunodeficiency virus-infected women. J. Clin. Microbiol. 43, 4607-4612 (2005).
15. Schwebke, J. R. , Hillier, S. L. , Sobel, J. D. , McGregor, J. A. Sweet, R. L. Validity of the vaginal gram stain for the diagnosis of bacterial vaginosis. Obstet. Gynecol. 88, 573-576 (1996).
16. Mayers, J. R. et al. Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development. Nat. Med. 20, 1193-1198 (2014).
17. Sreekumar, A. et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457, 910-914 (2009).
18. Wikoff, W. R. et al. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc. Natl. Acad. Sci. USA 106, 3698-3703 (2009).
19. Shannon, C. E. The mathematical theory of communication. 1963. MD Comput. 14, 306-317 (1997).
20. Zhou, X. et al. The vaginal bacterial communities of Japanese women resemble those of women in other racial groups. FEMS Immunol. Med. Microbiol. 58, 169-181 (2010).
21. Ison, C. A. , Easmon, C. S. , Dawson, S. G. , Southerton, G. Harris, J. W. Non-volatile fatty acids in the diagnosis of non-specific vaginitis. J. Clin. Pathol. 36, 1367-1370 (1983).
22. Piot, P. , Van Dyck, E. , Godts, P. Vanderheyden, J. The vaginal microbial flora in non-specific vaginitis. Eur. J. Clin. Microbiol. 1, 301-306 (1982).
23. Al-Mushrif, S. , Eley, A. Jones, B. M. Inhibition of chemotaxis by organic acids from anaerobes may prevent a purulent response in bacterial vaginosis. J. Med. Microbiol. 49, 1023-1030 (2000).
24. Kaneuchi, C. , Seki, M. Komagata, K. Production of succinic acid from citric acid and related acids by Lactobacillus strains. Appl. Environ. Microbiol. 54, 3053-3056 (1988).
25. Bisanz, J. E. et al. Microbiota at Multiple Body Sites during Pregnancy in a Rural Tanzanian Population and Effects of Moringa- Supplemented Probiotic Yogurt. Appl. Environ. Microbiol. 81, 4965-4975 (2015).
26. Friedman, J. Alm, E. J. Inferring correlation networks from genomic survey data. PLoS Comput. Biol. 8, e1002687 (2012).
27. Fernandes, A. D. , Macklaim, J. M. , Linn, T. G. , Reid, G. Gloor, G. B. ANOVA-like differential expression (ALDEx) analysis for mixed population RNA-Seq. PLoS One 8, e67019 (2013).
28. Fernandes, A. D. et al. Unifying the analysis of high-throughput sequencing datasets: characterizing RNA-seq, 16S rRNA gene sequencing and selective growth experiments by compositional data analysis. Microbiome 2, 15-2618-2-15. eCollection 2014 (2014).
29. Sohling, B. Gottschalk, G. Molecular analysis of the anaerobic succinate degradation pathway in Clostridium kluyveri. J. Bacteriol. 178, 871-880 (1996).
30. Scherf, U. , Sohling, B. , Gottschalk, G. , Linder, D. Buckel, W. Succinate-ethanol fermentation in Clostridium kluyveri: purification and characterisation of 4-hydroxybutyryl-CoA dehydratase/vinylacetyl-CoA delta 3-delta 2-isomerase. Arch. Microbiol. 161, 239-245 (1994).
31. Macklaim, J. M. et al. Comparative meta-RNA-seq of the vaginal microbiota and differential expression by Lactobacillus iners in health and dysbiosis. Microbiome 1, 12-2618-1-12 (2013).
32. Srinivasan, S. et al. Metabolic signatures of bacterial vaginosis. MBio 6, doi: 10. 1128/mBio. 00204-15 (2015).
33. Liebich, H. M. Forst, C. Hydroxycarboxylic and oxocarboxylic acids in urine: products from branched-chain amino acid degradation and from ketogenesis. J. Chromatogr. 309, 225-242 (1984).
34. Kawai, S. et al. Purification and characterization of a malic enzyme from the ruminal bacterium Streptococcus bovis ATCC 15352 and cloning and sequencing of its gene. Appl. Environ. Microbiol. 62, 2692-2700 (1996).
35. Pine, L. , Malcolm, G. B. , Brooks, J. B. Daneshvar, M. I. Physiological studies on the growth and utilization of sugars by Listeria species. Can. J. Microbiol. 35, 245-254 (1989).
36. Novak, L. Loubiere, P. The metabolic network of Lactococcus lactis: distribution of (14)C-labeled substrates between catabolic and anabolic pathways. J. Bacteriol. 182, 1136-1143 (2000).
37. Yeoman, C. J. et al. A multi-omic systems-based approach reveals metabolic markers of bacterial vaginosis and insight into the disease. PLoS One 8, e56111 (2013).
38. Fettweis, J. M. et al. Differences in vaginal microbiome in African American women versus women of European ancestry. Microbiology 160, 2272-2282 (2014).
39. McMillan, A. et al. A multi-platform metabolomics approach identifies novel biomarkers associated with bacterial diversity in the human vagina. arXiv:1504. 02816v1 [q-bio. BM] (2015).
40. Kohlmeier, K. A. , Vardar, B. Christensen, M. H. gamma-Hydroxybutyric acid induces actions via the GABAB receptor in arousal and motor control-related nuclei: Implications for therapeutic actions in behavioral state disorders. Neuroscience 248, 261-277 (2013).
41. Absalom, N. et al. alpha4betadelta GABA(A) receptors are high-affinity targets for gamma-hydroxybutyric acid (GHB). Proc. Natl. Acad. Sci. USA 109, 13404-13409 (2012).
42. Connelly, W. M. , Errington, A. C. Crunelli, V. gamma-Hydroxybutyric acid (GHB) is not an agonist of extrasynaptic GABAA receptors. PLoS One 8, e79062 (2013).
43. Aagaard, K. et al. A metagenomic approach to characterization of the vaginal microbiome signature in pregnancy. PLoS One 7, e36466 (2012).
44. Romero, R. et al. The composition and stability of the vaginal microbiota of normal pregnant women is different from that of non-pregnant women. Microbiome 2, 4-2618-2-4 (2014).
45. MacIntyre, D. A. et al. The vaginal microbiome during pregnancy and the postpartum period in a European population. Sci. Rep. 5, 8988 (2015).
46. Laghi, L. et al. Rifaximin modulates the vaginal microbiome and metabolome in women affected by bacterial vaginosis. Antimicrob. Agents Chemother. 58, 3411-3420 (2014).
47. Gajer, P. et al. Temporal dynamics of the human vaginal microbiota. Sci. Transl. Med. 4, 132ra52 (2012).
48. Gloor, G. B. et al. Microbiome profiling by illumina sequencing of combinatorial sequence-tagged PCR products. PLoS One 5, e15406 (2010).
49. Aitchison, J. The Statistical Analysis of Compositional Data. London: Chapman & Hall (1986).
50. Stein, S. An integrated method for spectrum extraction and compound identification from GC/MS data. J Am Soc Mass Spectrom 10, 70-781 (1999).
51. Styczynski, M. P. et al. Systematic identification of conserved metabolites in GC/MS data for metabolomics and biomarker discovery. Anal. Chem. 79, 966-973 (2007).
52. Benjamini, Y. Hochberg, Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J. R. Statist. Soc. B. 57, 289-300 (1995).
53. Kessner, D. , Chambers, M. , Burke, R. , Agus, D. Mallick, P. ProteoWizard: open source software for rapid proteomics tools development. Bioinformatics 24, 2534-2536 (2008).
54. Pluskal, T. , Castillo, S. , Villar-Briones, A. Oresic, M. MZmine 2: modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinformatics 11, 395-2105-11-395 (2010).
55. Smith, C. A. et al. METLIN: a metabolite mass spectral database. Ther. Drug Monit. 27, 747-751 (2005).
56. Wishart, D. S. et al. HMDB 3. 0-The Human Metabolome Database in 2013. Nucleic Acids Res. 41, D801-7 (2013).
57. Lopez-Raton, M. et al. OptimalCutpoints: An R Package for Selecting Optimal Cutpoints in Diagnostic Tests. J Stat Softw. 61, 1-36 (2014).
58. Youden, W. J. Index for rating diagnostic tests. Cancer 3, 32-35 (1950).